Magnetom Free.Max
Payments companies reported to CMS as associated with Magnetom Free.Max. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Magnetom Free.Max, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Magnetom Free.Max
These are the largest totals companies reported as associated with Magnetom Free.Max. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Matthias Benz | Los Angeles, CA | Diagnostic Radiology | $19,086.13 |
| Christopher Hess | San Francisco, CA | Diagnostic Radiology | $13,665.52 |
| Kimberly Kallianos | San Francisco, CA | Diagnostic Radiology | $12,207.52 |
| Michael Ohliger | Boston, MA | Internal Medicine | $12,153.88 |
| Javier Villanueva-Meyer | San Francisco, CA | Diagnostic Radiology | $12,027.52 |
| Benjamin Gordon | Murray, UT | Diagnostic Radiology | $11,894.68 |
| Garry Gold | Stanford, CA | Diagnostic Radiology | $11,782.33 |
| Bruce Daniel | Stanford, CA | Diagnostic Radiology | $10,769.95 |
| James Carr | Chicago, IL | Diagnostic Radiology | $9,259.52 |
| Bradley Allen | Chicago, IL | Diagnostic Radiology | $9,259.52 |
Prescribed Magnetom Free.Max?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.